These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26998220)

  • 1. Intermediate hepatocellular carcinoma: the role of transarterial therapy.
    Chegai F; Orlacchio A; Merolla S; Monti S; Mannelli L
    Hepat Oncol; 2015 Oct; 2(4):399-408. PubMed ID: 26998220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial Chemoembolization and Unresectable Hepatocellular Carcinoma: A Narrative Review.
    Manjunatha N; Ganduri V; Rajasekaran K; Duraiyarasan S; Adefuye M
    Cureus; 2022 Aug; 14(8):e28439. PubMed ID: 36176866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional
    Song JE; Kim DY
    World J Hepatol; 2017 Jun; 9(18):808-814. PubMed ID: 28706579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
    Ludwig JM; Zhang D; Xing M; Kim HS
    Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
    Minocha J; Salem R; Lewandowski RJ
    Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical Practice.
    Chai NX; Chapiro J
    Semin Intervent Radiol; 2020 Dec; 37(5):456-465. PubMed ID: 33328701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.
    Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH
    Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
    Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
    J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
    BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage.
    Cappelli A; Sangro P; Mosconi C; Deppe I; Terzi E; Bilbao JI; Rodriguez-Fraile M; De Benedittis C; Ricke J; Golfieri R; Sangro B
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):661-668. PubMed ID: 30209522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
    Kim DY; Han KH
    Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
    Tsochatzis EA; Germani G; Burroughs AK
    Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New concepts in embolotherapy of HCC.
    Pesapane F; Nezami N; Patella F; Geschwind JF
    Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review.
    Sacco R; Tapete G; Simonetti N; Sellitri R; Natali V; Melissari S; Cabibbo G; Biscaglia L; Bresci G; Giacomelli L
    J Hepatocell Carcinoma; 2017; 4():105-110. PubMed ID: 28795053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
    Fidelman N; Kerlan RK
    AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small molecules.
    Gutierrez JA; Gish RG
    Transl Cancer Res; 2013 Dec; 2(6):460-471. PubMed ID: 26504748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
    Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
    J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraarterial Therapies for the Management of Hepatocellular Carcinoma.
    Garg T; Shrigiriwar A; Habibollahi P; Cristescu M; Liddell RP; Chapiro J; Inglis P; Camacho JC; Nezami N
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.